Measurement of Fecal Calprotectin Improves Monitoring and Detection of Recurrence of Crohn's Disease After Surgery
- 1 May 2015
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 148 (5) , 938-947.e1
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel diseaseInflammatory Bowel Diseases, 2012
- Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel diseaseInflammatory Bowel Diseases, 2009
- Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's DiseaseClinical Gastroenterology and Hepatology, 2008
- Non-invasive techniques for assessing postoperative recurrence in Crohn's diseaseDigestive and Liver Disease, 2008
- Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findingsInflammatory Bowel Diseases, 2008
- European evidence based consensus on the diagnosis and management of Crohn’s disease: special situationsGut, 2006
- Predictability of the postoperative course of Crohn's diseaseGastroenterology, 1990
- Are activity indices helpful in assessing active intestinal inflammation in Crohn's disease?Gut, 1989
- Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery.Gut, 1984
- Development of a Crohn's Disease Activity IndexGastroenterology, 1976